— Partnership provides additional growth capital, supported by OneOncology’s investors, TPG and Cencora, to expand comprehensive high-value urology care in physician-owned practices and ambulatory surgery centers

— Culture of physician leadership and organic growth is highly complementary to OneOncology

— Increasing complexity of prostate, bladder, and other genitourinary cancers means partnership between OneOncology and United Urology Group will drive meaningful improvement to cancer care

Nashville, TN, and Owings Mills, MD – August 20, 2024 — OneOncology, the fastest-growing national platform for independent oncology practices, today announced that it has agreed to acquire United Urology Group (“UUG”), one of the nation’s leading urology management services organizations supporting approximately 250 physicians and advanced practice providers with more than 1,300 employees. UUG’s vision is to lead the transformation of urology through its commitment to accessible, high quality, and value-based care; patient and employee satisfaction; continuous innovation; and community involvement.

“UUG’s attention and dedication to physician centricity and partnership with its leading independent practices is directly aligned with OneOncology’s culture and philosophy,” said Jeff Patton, MD, Chief Executive Officer, OneOncology. “We are thrilled to partner with the physician and executive leadership of United Urology Group to continue advancing urology care, including the increasingly complex treatment of genitourinary cancers.”

Urologists are critical members of the cancer care ecosystem, serving as the quarterbacks for cancer care for prostate, bladder, and other genitourinary cancers. Prostate cancer incidence rates have grown by approximately 3% per year over the last decade, creating a high unmet need for these services. In 2024, the American Cancer Society estimates there to be almost 300,000 newly diagnosed cases of prostate cancer in the United States with prostate cancer being the second-leading cause of cancer death in American men.

“We at UUG have built something truly unique in the urologic space, offering affiliate practices the support they need to elevate their services while reducing administrative and financial burdens for physicians. I am incredibly proud of our team and excited about the opportunity to unite these two outstanding organizations. With OneOncology’s proven track record of growth, we are eager to extend our fully integrated care ecosystem to more independent urology practices. We look forward to enhancing access to high-quality ancillary services for both practices and their patients," said Ian Wong, Chief Executive Officer, UUG.

United Urology Group has demonstrated unparalleled operational leadership, integrating its affiliate practices with sophisticated technology systems and processes. This has enabled the company to broaden the breadth of ancillary service lines its affiliate practices provide by offering comprehensive, lower-cost and integrated care to its patients in its physician offices and ambulatory surgery centers. With these capabilities, UUG has created a platform for sustainable growth, partnering with its affiliated practices and providers to improve their economics while maintaining a high level of patient care.

“I am energized about the opportunities that this new relationship brings. The synergies between OneOncology and United Urology Group are going to allow us to enhance care to our complex urologic oncology patients and provide the ideal patient experience to all our urology patients across our expanding platform,” said Geoffrey Sklar, MD, Chief Medical Officer, UUG.

Debevoise & Plimpton LLP and Sheppard Mullin served as legal counsel to OneOncology, while Ropes & Gray LLP and McGuire Woods served in the same capacity to the seller. Houlihan Lokey served as financial advisor to UUG. The transaction is expected to close by the end of 2024.